Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer

Elizabeth David; David T Cooke; Yingjia Chen; Andrew Perry; Robert J Canter; Rosemary D Cress

doi:10.1016/j.amjsurg.2015.05.002

Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer

Elizabeth David, David T Cooke, Yingjia Chen, Andrew Perry, Robert J Canter, Rosemary D Cress

Research output: Contribution to journal › Article

16 Scopus citations

Abstract

Background Quality of oncologic outcomes is of paramount importance in the care of patients with non-small cell lung cancer (NSCLC). We sought to evaluate the relationship of hospital volume for lobectomy on cancer-specific survival in NSCLC patients treated in California, as well as the influence of Commission on Cancer (CoC) accreditation. Methods The California Cancer Registry was queried from 2004 to 2011 for cases of Stage I NSCLC and 8,345 patients were identified. Statistical analysis was used to determine prognostic factors for cancer-specific survival. Results A total of 7,587 patients were treated surgically. CoC accreditation was not significant for cancer-specific survival, but treatment in high-volume centers was associated with longer survival when compared with low- and medium-volume centers (hazard ratio 1.77, 1.474 to 2.141 and hazard ratio 1.23, 1.058 to 1.438).

Original language	English (US)
Pages (from-to)	643-647
Number of pages	5
Journal	American Journal of Surgery
Volume	210
Issue number	4
DOIs	https://doi.org/10.1016/j.amjsurg.2015.05.002
State	Published - Oct 1 2015

Keywords

Cancer-specific survival
Commission on cancer accreditation
Lobectomy
Non-small cell lung cancer
Sublobar resection
Thoracic surgery

ASJC Scopus subject areas

Surgery

Access to Document

10.1016/j.amjsurg.2015.05.002

Fingerprint Dive into the research topics of 'Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer'. Together they form a unique fingerprint.

Cite this

David, E., Cooke, D. T., Chen, Y., Perry, A., Canter, R. J., & Cress, R. D. (2015). Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer. American Journal of Surgery, 210(4), 643-647. https://doi.org/10.1016/j.amjsurg.2015.05.002

Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer. / David, Elizabeth ; Cooke, David T; Chen, Yingjia; Perry, Andrew; Canter, Robert J ; Cress, Rosemary D.

In: American Journal of Surgery, Vol. 210, No. 4, 01.10.2015, p. 643-647.

Research output: Contribution to journal › Article

@article{05be818e66e345fb9b91804a8316df6c,

title = "Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer",

abstract = "Background Quality of oncologic outcomes is of paramount importance in the care of patients with non-small cell lung cancer (NSCLC). We sought to evaluate the relationship of hospital volume for lobectomy on cancer-specific survival in NSCLC patients treated in California, as well as the influence of Commission on Cancer (CoC) accreditation. Methods The California Cancer Registry was queried from 2004 to 2011 for cases of Stage I NSCLC and 8,345 patients were identified. Statistical analysis was used to determine prognostic factors for cancer-specific survival. Results A total of 7,587 patients were treated surgically. CoC accreditation was not significant for cancer-specific survival, but treatment in high-volume centers was associated with longer survival when compared with low- and medium-volume centers (hazard ratio 1.77, 1.474 to 2.141 and hazard ratio 1.23, 1.058 to 1.438).",

keywords = "Cancer-specific survival, Commission on cancer accreditation, Lobectomy, Non-small cell lung cancer, Sublobar resection, Thoracic surgery",

author = "Elizabeth David and Cooke, {David T} and Yingjia Chen and Andrew Perry and Canter, {Robert J} and Cress, {Rosemary D}",

year = "2015",

month = oct,

day = "1",

doi = "10.1016/j.amjsurg.2015.05.002",

language = "English (US)",

volume = "210",

pages = "643--647",

journal = "American Journal of Surgery",

issn = "0002-9610",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer

AU - David, Elizabeth

AU - Cooke, David T

AU - Chen, Yingjia

AU - Perry, Andrew

AU - Canter, Robert J

AU - Cress, Rosemary D

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background Quality of oncologic outcomes is of paramount importance in the care of patients with non-small cell lung cancer (NSCLC). We sought to evaluate the relationship of hospital volume for lobectomy on cancer-specific survival in NSCLC patients treated in California, as well as the influence of Commission on Cancer (CoC) accreditation. Methods The California Cancer Registry was queried from 2004 to 2011 for cases of Stage I NSCLC and 8,345 patients were identified. Statistical analysis was used to determine prognostic factors for cancer-specific survival. Results A total of 7,587 patients were treated surgically. CoC accreditation was not significant for cancer-specific survival, but treatment in high-volume centers was associated with longer survival when compared with low- and medium-volume centers (hazard ratio 1.77, 1.474 to 2.141 and hazard ratio 1.23, 1.058 to 1.438).

AB - Background Quality of oncologic outcomes is of paramount importance in the care of patients with non-small cell lung cancer (NSCLC). We sought to evaluate the relationship of hospital volume for lobectomy on cancer-specific survival in NSCLC patients treated in California, as well as the influence of Commission on Cancer (CoC) accreditation. Methods The California Cancer Registry was queried from 2004 to 2011 for cases of Stage I NSCLC and 8,345 patients were identified. Statistical analysis was used to determine prognostic factors for cancer-specific survival. Results A total of 7,587 patients were treated surgically. CoC accreditation was not significant for cancer-specific survival, but treatment in high-volume centers was associated with longer survival when compared with low- and medium-volume centers (hazard ratio 1.77, 1.474 to 2.141 and hazard ratio 1.23, 1.058 to 1.438).

KW - Cancer-specific survival

KW - Commission on cancer accreditation

KW - Lobectomy

KW - Non-small cell lung cancer

KW - Sublobar resection

KW - Thoracic surgery

UR - http://www.scopus.com/inward/record.url?scp=84941940407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941940407&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2015.05.002

DO - 10.1016/j.amjsurg.2015.05.002

M3 - Article

C2 - 26193801

AN - SCOPUS:84941940407

VL - 210

SP - 643

EP - 647

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 4

ER -